Repeated injection into the identical spot causes lipohypertrophy, a localized thickening of subcutaneous fat that can impair drug absorption
Key Cited Studies Monnier M, Dudler L, Gchter R, Schoenenberger GA (1977) Delta-sleep inducing peptide (DSIP): EEG and motor activity in rabbits following intravenous administration
"FDA remains committed to facilitating the development and approval of additional safe and effective therapies for adults with obesity or overweight." The drug, semaglutide, known commercially as Wegovy, was previously approved for FDA use at a lower dose for Type 2 diabetes treatment
in Pizhou, ferulic acid, naringenin, apigenin, and quercetin
doi:10.3390/ijms19071987 Campbell JD, McDonough JE, Zeskind JE, et al
Formulations compatible with oral dosing are expected to increase use of these medicines and to benefit patient compliance